MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Patients With Advanced Parkinson’s Disease

    M. Soileau, F. Pagan, A. Fasano, R. Rodriguez, N. Gupta, A. Xi, M. Kambhampati, A. Murunga, C. Teigland, P. Kandukuri, Y. Jalundhwala, O. Ladhani, M. Siddiqui (Georgetown, USA)

    Objective: To evaluate real-world comparative effectiveness of Carbidopa/Levodopa Enteral Suspension (CLES) versus Deep Brain Stimulation (DBS) initiation on pill burden reduction in patients with Advanced…
  • MDS Virtual Congress 2021

    Unusual Progressive Supranuclear Palsy: a case report

    L. Megherbi, H. Si Ahmed, S. Daoudi (Tizi Ouzou, Algeria)

    Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…
  • MDS Virtual Congress 2021

    Characteristics of daily exercise patterns in various stages of Parkinson’s disease

    J. Song, JK. Mun, JH. Ahn, J. Youn, I. Choi, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate the patterns of exercise in the daily lives of mild to severe PD patients. Background: Despite the reported clinical impact of exercise…
  • MDS Virtual Congress 2021

    Perampanel inhibits α-synuclein transmission in Parkinson’s disease models

    J. Ueda, N. Uemura, R. Takahashi (Kyoto, Japan)

    Objective: To examine the effect of perampanel, an antiepileptic drug, on α-synuclein transmission in cultured cells and mouse models of Parkinson’s disease. Background: The intercellular transmission of pathogenic proteins…
  • MDS Virtual Congress 2021

    Effects of levodopa on cognitive functions in Parkinson’s disease

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

    Objective: To assess the dynamics of cognitive functions (CF) under the influence of levodopa in PD patients Background: Our research is devoted to an urgent problem-the…
  • MDS Virtual Congress 2021

    The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

    Objective: This study examines whether severity and the functional impact of cognitive decline in Parkinson’s disease mild cognitive impairment (PD MCI) participants differ between those…
  • MDS Virtual Congress 2021

    Parkin Mutation and Deep Brain Stimulation

    E. Erdil, H. Omercikoglu, F. Bayraklı, D. Gunal (Istanbul, Turkey)

    Objective: To investigate the clinical features of Parkin mutated patients who undergone subthalamic brain stimulation (DBS group) and pharmalogically treated only (Non-DBS group). Background: The…
  • MDS Virtual Congress 2021

    HYPERSEXUAL DISORDER IN GBA-ASSOCIATED PARKINSON’S DISEASE: CASE REPORT

    M. Montenegro, C. Malcher, V. Cardoso, A. Escudeiro, A. Silva, B. Santos-Lobato (Belém, Brazil)

    Objective: To describe a patient with PD and hypersexual disorder carrying a GBA variant. Background: Compulsive sexual behavior occurs in 4% of patients with Parkinson’s…
  • MDS Virtual Congress 2021

    The MJFF Global Genetic Parkinson’s Disease Research Resource

    EJ. Vollstedt, JO. Aasly, B. Al Mubarak, R. Alcalay, V. Alvarez, I. Amorin, G. Annesi, D. Arkadir, M. Barkhuizen, D. Berg, V. Bonifati, A. Boon, L. Brighina, K. Brockmann, A. Carmine Belin, J. Carr, J. Clarimon, M. Cornejo-Olivas, JC. Corvol, D. Crosiers, J. Damasio, P. Das, P. Carvalho Aguiar, A. de Rosa, J. Dorszewska, S. Ertan, R. Ferese, J. Ferreira, E. Gatto, N. Giladi, H. Hanagasi, N. Hattori, F. Hentati, S. Illarioshkin, J. Jankovic, P. Klivenyi, V. Kostic, D. Koziorowski, A. Lang, SY. Lim, CH. Lin, K. Lohmann, M. Martikainen, G. Mellick, M. Merello, P. Mir, M. Pimentel, T. Pulkes, A. Puschmann, E. Sammler, M. Skaalum Petersen, M. Skorvanek, M. Spitz, L. Stefanis, O. Suchowersky, V. Tumas, EM. Valente, B. de Warrenburg, C. Williams-Gray, R. Wu, B. Zhang, A. Zimprich, C. Klein (Luebeck, Germany)

    Objective: To establish a comprehensive research and clinical trial-ready resource of centers working with individuals with monogenic Parkinson’s Disease (PD). Background: As gene-targeted therapies are…
  • MDS Virtual Congress 2021

    The gut microbiome in Parkinson’s disease: longitudinal insights into disease progression and the use of device-assisted therapies.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

    Objective: We investigated the temporal stability of gut microbiome (GM) profiles from Parkinson’s disease (PD) patients initiating device-assisted therapies (DAT) and in a separate cohort…
  • « Previous Page
  • 1
  • …
  • 528
  • 529
  • 530
  • 531
  • 532
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley